AV-001 or Placebo Injection clinical trials

Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury.

This study looks into a new drug, AV-001, for people on regular kidney dialysis. It aims to see if the drug can protect the brain from damage caused by dialysis, which can lead to problems with memory and thinking.